Medical Oncology Prof. Dr. Özlem Er
✓ Medically verified profileProf. Dr. Özlem Er
✓ Medically verified profile
About Prof. Dr. Özlem Er
Quick answer
Prof. Dr. Özlem Er is a Medical Oncology specialist at Acibadem Maslak Hospital in İstanbul with 32+ years of experience.
She treats breast cancer, breast cancer liver metastases, gastrointestinal stromal tumors, renal cell carcinoma, hepatocellular carcinoma, advanced and metastatic gastric cancer, small cell lung cancer, and cancer-associated venous thrombosis, and manages systemic chemotherapy including capecitabine, cisplatin-based chemotherapy, irinotecan plus cisplatin, and low-molecular-weight heparin therapy. Consultations are available in Turkish and English, including…
Prof. Özlem Er is a medical oncologist with a strong academic and clinical background. She earned her professorship from Acibadem University Faculty of Medicine in 2010 and has been affiliated with Acibadem Health Group since 2018. Her work focuses on advancing cancer care through clinical practice, research, and collaboration.
Active in the oncology community, Prof. Er holds memberships in leading professional organizations, including ASCO (American Society of Clinical Oncology), ESMO (European Society for Medical Oncology), the Turkish Oncology Group, the Medical Oncology Society, and the Turkish Cancer Research and Control Society. These affiliations reflect her commitment to staying current with oncology advances and contributing to multidisciplinary efforts in cancer treatment and control.
Areas of Expertise
Conditions treated and procedures performed by this specialist.
Education
- 2010Acibadem University Faculty of Medicine / Professor
- 2003Erciyes University Faculty of Medicine / Associate Professor
- 2002Erciyes University Faculty of Medicine Medical Oncology
- 1999Ankara Numune Training and Research Hospital Internal Medicine
- 1994Hacettepe University Faculty of Medicine
Professional Experience
- 2018Acibadem Health Group
- 2006–2008Thomas Jefferson University Breast Cancer Research (Research Fellow)
- 2005–2007Head of Department of Medical Oncology, Erciyes University Faculty of Medicine
- 2003–2004MD Anderson Cancer Center Breast Cancer Clinical Research (Clinical Observer)
- 2002–2009Erciyes University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology, Faculty Member
- 1999–2002Erciyes University Faculty of Medicine Medical Oncology Residency
- 1994–1999Ankara Numune Training and Research Hospital Internal Medicine Residency
Professional Memberships
- ASCO (American Society Of Clinical Oncology)
- ESMO (European Society or Medical Oncology)
- Turkish Oncology Group
- Medical Oncology Society
- Turkish Cancer Research and Control Society
Selected Publications
- Cyclooxygenase-2 expression in gastrointestinal stromal tumors. Asian Pac J Cancer Prev. 2010;11(4):849-53 Sevinc A, Camci C, Sari I, Kalender ME, Er O, Soyuer I, Dikilitas M, Yilmaz U, Sagol O, Alacacioglu A.
- Intramuscular metastases detected by PET/CT in a patient with renal cell tumor. V Beylergil, O. Er, Z. Calıkuşu, E. Vardareli. Acibadem University Journal of Health Sciences 2010: 1: 49-50
- Capecitabine:Use except in breast and colorectal cancers. Remission Journal of Current Oncology 2010: 10 (1): 27-39 Ozlem Er, Halit Karaca.
- ERCC1 is not expressed in hepatocellular cancer: A Turkish Oncology Group. Journal of BUON 2010;15:794-796 N. Serdar Turhal, E. Bas, O. Er, M. Aliustaoglu, S. Seber, F. Dane, T. Korkmaz, I. Soyuer, S. Ozkara, C. Celikel.
- Prognostic value of excision repair cross-complementing gene 1 expression for cisplatin-based chemotherapy in advanced gastric cancer. Asian Pac J Cancer Prev. 2010;11(1):181-5 Ozkan M, Akbudak IH, Deniz K, Dikilitas M, Dogu GG, Berk V, Karaca H, Er O, Altinbas M.
- Clinical Course Of Breast Cancer Patients With Metastases Limited To The Liver Treated With Chemotherapy. Er O, Frye Dk, Kau Sw, Broglio K, Valero V, Hortobagyi Gn, Arun B.Cancer J. 2008
- Protective Effects Of Carvedilol Against Anthracycline-Induced Cardiomyopathy. Kalay N, Basar E, Ozdogru I, Er O, Cetinkaya Y, Dogan A, Inanc T, Oguzhan A, Eryol Nk, Topsakal R, Ergin A. J Am Coll Cardiol. 2006
- Management of Cancer-Associated Venous Thrombosis. Er O, Zacharski L. Vasc Health Risk Manag. 2006
- Irinotecan Plus Cisplatin Combination Against Metastatic Gastric Cancer: Phase Ii Study. Altinbas M, Er O, Ozkan M, Solak Y, Coskun Hs, Kucuk C, Gursoy S. Med Oncol. 2005
- A Randomized Clinical Trial Of Combination Chemotherapy With And Without Low-Molecular-Weight Heparin In Small Cell Lung Cancer. Altinbas M, Coskun Hs, Er O, Ozkan M, Eser B, Unal A, Cetin M, Soyuer S. J Thromb Haemost. 2004
Frequently Asked Questions
What is Dr. Özlem Er's specialty?
Which hospital does Dr. Özlem Er practise at?
What languages can I use when consulting Dr. Özlem Er?
How can I book an appointment with Dr. Özlem Er?
Is an online video consultation available with Dr. Özlem Er?
How many years of experience does Dr. Özlem Er have?
Can international patients arrange treatment with Dr. Özlem Er?
How do I get a second opinion involving Dr. Özlem Er?
A dedicated team, from first message to follow-up
Our international patient office coordinates your appointment, travel and treatment at JCI-accredited Acıbadem hospitals — and stays with you in your own language, every step of the way.
Schedule your appointment with Prof. Dr. Özlem Er
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.
